Pasar al contenido principal

NUEVAS HERRAMIENTAS TERAPEUTICAS FRENTE A ENFERMEDADES INFECCIOSAS OLVIDADAS O (RE)EMERGENTES (LEISHMANIASIS O VIRUS CON POTENCIAL PANDEMICO, INFLUENZA Y CORONAVIRUS)

PID2022-136307OB-C21

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Design, synthesis and structure-activity relationship (SAR) studies of an unusual class of non-cationic fatty amine-tripeptide conjugates as novel synthetic antimicrobial agents

  • Hernández-Ortiz, Noelia
  • Sánchez-Murcia, Pedro A.
  • Gil-Campillo, Celia
  • Domenech, Mirian
  • Lucena-Agell, Daniel
  • Hortigüela, Rafael
  • Velázquez, Sonsoles
  • Camarasa Rius, María José
  • Bustamante, Noemí
  • Castro, Sonia de
  • Menéndez, Margarita
Cationic ultrashort lipopeptides (USLPs) are promising antimicrobial candidates to combat multidrug-resistant bacteria. Using DICAMs, a newly synthesized family of tripeptides with net charges from −2 to +1 and a fatty amine conjugated to the C-terminus, we demonstrate that anionic and neutral zwitterionic USLPs can possess potent antimicrobial and membrane- disrupting activities against prevalent human pathogens such as Streptococcus pneumoniae and Streptococcus pyogenes. The strongest antimicrobials completely halt bacterial growth at low micromolar concentrations, reduce bacterial survival by several orders of magnitude, and may kill planktonic cells and biofilms. All of them comprise either an anionic or neutral zwitterionic peptide attached to a long fatty amine (16–18 carbon atoms) and show a preference for anionic lipid membranes enriched in phosphatidylglycerol (PG), which excludes electrostatic interactions as the main driving force for DICAM action. Hence, the hydrophobic contacts provided by the long aliphatic chains of their fatty amines are needed for DICAM’s membrane insertion, while negative-charge shielding by salt counterions would reduce electrostatic repulsions. Additionally, we show that other components of the bacterial envelope, including the capsular polysaccharide, can influence the microbicidal activity of DICAMs. Several promising candidates with good-to-tolerable therapeutic ratios are identified as potential agents against S. pneumoniae and S. pyogenes. Structural characteristics that determine the preference for a specific pathogen or decrease DICAM toxicity have also been investigated., The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by grants of the Ministry of Science, Innovation and Universities (RTI2018-099985-B-I00/AEI/10.13039/501100011033) to MM and (PID2022-136307OB-C21/AEI/10.13039/ 501100011033/FEDER, UE) to MC, SV, and SC, and by a grant from the Ministry of Science and Innovation (PID2019-104070-RB- C21) to MC, and SV. Additional funding was provided by the Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), an initiative of the Instituto de Salud Carlos III (ISCIII) to MM (CB06/06/1102) and MD (CB06/06/0003), and by Agencia Estatal Consejo Superior de Investigaciones Científicas, CSIC, (Projects CSIC-PIE201980E100, CSIC-PIE201980E028 and CSIC- PIE202380E095) to MC, SV, and SC., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Skeletal Transformations Observed in the Reaction of a Tricyclic Thymine Nucleoside with Dicarbonyl Compounds

  • Bonache, María-Cruz
  • Doyagüez, Elisa G.
  • Benito-Arenas, Raúl
  • Bonache de Marcos, María Ángeles
  • Jimeno, M. Luisa
  • San-Félix, Ana
This work is dedicated to the memory of Dr. Sonsoles Velázquez (IQM-CSIC, Spain), an extraordinary scientist whose courage and exemplary dedication to medicinal chemistry, family and friends will live on for many years, Some intriguing skeletal transformations were observed in the reaction of α-hydroxypyrrolidine thymine nucleoside 2 with different dicarbonyl compounds. In these reactions, unusual ring systems, together with new C−C bonds and stereogenic centers of defined configuration, were formed in a single step. These reactions were initiated by the nucleophilic attack of the NH of the pyrrolidine ring, present on 2, on one of the carbonyl moieties of a dicarbonyl reagent and seem to proceed through an enamine−iminium mechanism. The present methodology is particularly attractive because no catalyst or aggressive conditions are needed. The new polycyclic nucleosides obtained from 2 can be good scaffolds for diversification. In fact, modification and derivatization can be achieved by performing further chemical transformations of the functional groups present in some of them. This may lead to the formation of new highly functionalized nucleosides. Our results show the high synthetic potential of 2 to construct complex systems in an efficient way. On the other hand, the enamine chemistry involved in the particular reactivity of the α-hydroxy pyrrolidine ring present in 2 has no connection with the nucleobase and could be extended to simple glycosides preserving this essential ring system, We thank Susana Ruiz for excellent technical assistance. The Spanish Ministerio de Ciencia, Innovación y Universidades (MCIU) (project: PID2022-136307OB-C21/AEI/10.13039/ 501100011033/FEDER,UE) is also acknowledged for financial support., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A tetrapodal tryptophan derivative with multiple exposed free carboxylic acids blocks host cell entry of omicron SARS-Cov-2 and respiratory syncytial virus

  • Martí-Marí, Olaia
  • Moreno-Simoni, Marta
  • Avilés-Alía, Ana Isabel
  • Rusu, Luciana
  • Forcada-Nadal, Alicia
  • Adhav, Anmol
  • López-Redondo, Marisa
  • Blázquez, Ana-Belén
  • Esteban, Ana
  • Jiménez de Oya, Nereida
  • Marina, Alberto
  • Rubio, Vicente
  • Llácer, José Luis
  • Gago, Federico
  • Martín-Acebes, M. A.
  • Peréz-Pérez, María-Jesús
  • Geller, Ron
  • San-Félix, Ana
Omicron sublineages of SARS-CoV-2 have accelerated the spread of the virus and facilitated immune escape. In this work, we demonstrate that compound 2, a potent HIV and enterovirus A71 (EV-A71) entry inhibitor previously discovered in our research group, also displays potent in vitro activity against different SARS-CoV-2 Omicron variants while showing no activity against the ancestral SARS-CoV-2 Wuhan strain. Moreover, its sodium salt (2-Na salt) exhibited in vivo antiviral activity in a murine model of Omicron BA.1. infection. Indeed, biophysical and cryo-EM studies revealed binding of 2-Na salt to the Omicron BA.1 spike (S) protein stabilizing a "closed" form in which ∼75% of the S particles have all RBDs down, unlike the usual "open" form with one RBD up. Such "closed" form decreases S avidity for the cellular receptor ACE2, thus inhibiting viral entry. Computer-assisted modeling studies strongly suggest that 2 can interact with the intersubunit cavity of the S trimer of the Omicron BA.1 subvariant, making use of the multivalency principle. In this context, compound 2 can be considered a pharmacological tool for studying and validating new antiviral strategies against Omicron variants. We also identified 2 as a potent inhibitor of RSV and the Ebola virus. The effectiveness of 2 against a diverse set of viruses of different families supports its use as a promising lead for the development of entry inhibitors against current and future viral infections, representing a meaningful advance in the field., Funding for this project was provided by grants SGL2021-03-009, SGL2103053, and SGL2021-03-052 from European Union Next Generation EU/PRTR through the CSIC Global Health Platform established by EU Council Regulation 2020/2094. The work was also supported by the Spanish Ministry of Science and Innovation AEI/10.13039/501100011033/FEDER, UE under projects PID2022-137372OR-C22 (M.-J.P.-P.), PID2022-136307OB-C21 (A.S.-F.), and PID2022-136307OB-C22 (F.G.) together with CSIC Intramural projects PIE202380E090 (M.-J.P.-P. and A.S.-F.) and PIE 202340E181 (M.A.M.-A.). V.R. and J.L.L. acknowledge the financial support provided by MICIN (grants PID2020-120322RB-C21 and PID2020-116880GB-I00, respectively)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Influenza A virus hemagglutinin: from classical fusion inhibitors to proteolysis targeting chimera-based strategies in antiviral drug discovery

  • Hermoso-Pinilla, Francisco Javier
  • Valdivia, Aitor
  • Camarasa Rius, María José
  • Ginex, Tiziana
  • Luque, Francisco Javier
The influenza virus glycoprotein hemagglutinin (HA) participates in critical steps of the attachment of viral particles to the host cell membrane receptor and membrane fusion. Due to its crucial involvement in the initial phases of influenza A infections, HA emerges as a promising target in the search of novel drug-like candidates. Given its pivotal role in the early stages of influenza A infections, intense drug discovery efforts have been undertaken to target HA in the past decades. Drug discovery studies mainly rely on preventing the recognition of sialic acid units by the receptor binding site in the globular head (GH) domain, or the conformational rearrangement required for the fusion of viral and cell membranes. In this work, the aim is to summarize the progress made in HA-targeted development of small molecule fusion inhibitors. To this end, attention will primarily be focused on the analysis of the X-ray crystallographic structures of HA bound to fusion inhibitors. Furthermore, this study also aims to highlight the efforts made in exploiting the structural information in conjunction with molecular modeling techniques to discern the mechanism of action of the fusion inhibitors and to assist the design and interpretation of structure-activity relationships of novel lead compounds will be highlighted. The final section will be dedicated to elucidating novel and promising antiviral strategies proceeding from the transformation of known small molecule antivirals in proteolysis targeting chimera (PROTAC)-based targeted protein degradation. This knowledge will be valuable to assist the exploitation of classical and novel antiviral structure-based strategies, together with a deeper understanding of the mechanism of action and minimization of the impact of drug resistance., The research was given financial support by the Spanish Ministerio de Ciencia e Innovación [PID2020117646RB-I00 MCIN/AEI/10.13039/501100011033, PID2019-104070-RB-C21]; the Spanish Ministerio de Ciencia, Innovación y Universidades [PID2022-136307OB-C21/AEI/10.13039/501100011033/FEDER, UE]; Maria de Maetzu [CEX2021-001202-M]; Generalitat de Catalunya [2021SGR00671]; and Agencia Estatal Consejo Superior de Investigaciones Científicas (CSIC) [CSIC-PIE201980E100, CSICPIE201980E028, CSIC-PIE202380E095]. FJH has fellowship from the Spanish Ministerio de Ciencia e Innovación [PRE2021-100418]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Thioaryl imides, a novel familiy of potential SARS-COV-2 entry inhibitors identified through a high thoughput pseudotyped assay

  • Quesada, Ernesto
  • Lozano-Morcillo, Carla
  • Avilés-Alía, Ana Isabel
  • Fernández-Cabello, Víctor
  • Marlasca, Mónica
  • Camarasa Rius, María José
  • Peréz-Pérez, María-Jesús
  • Geller, Ron
Resumen del póster presentado a las IV Jornadas Científicas PTI+ Salud Global, celebradas del 28 al 29 de octubre de 2024 en el Auditorio Marie Curie – Parc Científic de la Unviersitat de València., Background. Although the WHO declared the end of the COVID-19 emergency in May 2023, the disease remains as a global public health threat and complete eradication of the causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains an elusive goal in the short to medium term1. Fortunately, this lethal pandemic has been controlled by the emergence of vaccines capable of inducing neutralizing antibodies that efficiently block infection. These vaccines were developed using revolutionary mRNA technical breakthroughs based on harmless fragments of the spike-shaped S protein (S-Protein). It must be noted that it is well established that SARS-CoV-2 infects cells through the interaction of the S-protein located on the surface of the virus with the angiotensin converting enzyme 2 (ACE2) cell receptors. In spite of these success, the main concerns regarding the contemporary clinical landscape of the disease are the emergence of new variants, particularly focused on mutations in the S-protein. Since the identification of the original Wuhan strain, there have been multiple variants of concern, like the Omicron variants, which evolved into five lineages, among them the XBB1.5, the currently most prevalent subvariant due to its enhanced immune evasion from protection provided by prior infections or vaccines. This emphasize the importance of identifying and developing new chemotherapeutics, including small molecules, to combat COVID infection by targeting the entry of the virus into the host cells as a still attractive strategy whether the antivirals under investigation are adapted to the prevalent S-protein variants2., Methods. High-throughput screening (HTS) assays based on pseudotyped vesicular stomatitis viruses expressing the currently prevailing S-protein of SARS-CoV-2 (VSV-S) can be considered as simple, reliable platforms for the rapid identification of novel compounds with potential as entry inhibitors (hits)3. We report herein the preliminary evaluation of a small chemical library on VSV-S pseudoparticles harboring the XBB.1.5 S protein in Vero E6 cells expressing the TMPRSS2 entry factor., Results. A library of 30 synthetic thioaryl imides provided by IQM were assayed by I2SysBio in this HTS platform. Evaluated compounds proved a noticeable ability to inhibit the virus attachment to the host cells, showing IC50 values in the range 0.2-7.0 µM whereas keeping selectivity indexes >10., Conclusions. The screening campaign allowed to identify a series of potential SARS-CoV-2 entry inhibitors (XBB.1.5). The most active molecule showed significant capability to selectively block the interaction between ACE2 and pseudotyped VSV-S (IC50=0.2 µM). Moreover, thioaryl imides are a largely unexplored family of chemicals. These promising results could encourage us to explore focused research aimed at providing a candidate with enhanced activity and improved properties for further evaluation., The Spanish Ministry of Science and Innovation AEI/10.13039/501100011033 (grants PID2022-136307OB- C21 and PID2022-137372OR-C22 (MICINN/AEI/10.13039/501100011033/ FEDER, UE) and NextGeneration (EU 2020/2094) CSIC Global Health Platform (PTI Salud Global) are acknowledged for financial support., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

TLR4 receptor blockade diminishes cardiac and renal toxicity induced by cisplatin treatment in rats

  • González-Ruiz, Antonio
  • Flaj, Silvia
  • Fernández-Cabello, Víctor
  • Quesada, Ernesto
  • López-Miranda, Visitación
  • Herradón, Esperanza
Cisplatin's use is limited by renal and cardiovascular toxicity, among others. This toxicity is mediated, in part, by the capacity of cisplatin to activate TLR4/MyD88/NLRP3 signaling cascade, leading to sterile inflammation. The aim of the present study is to evaluate whether blockade of TLR4 receptors can ameliorate cardio-renal toxicity induced by cisplatin, analyzing the modulation of oxidative stress and/or inflammatory pathways., “This research was funded by Spanish Ministry of Science and Innovation AEI/10.13039/501100011033 under grants SAF 2012- 40075-C02–01 and PID2022-136307OBC21 and from by the European Commission-NextGeneration EU (Regulation EU 2020/2094), through CSIC's Global Health Platform (PTI Salud Global). Victor Fernánez- Cabello has a contract from Community of Madrid co-financed by the European Social Fund Plus (ESF+) (Ref.PEJ-2020-AI/BMD-19284)., Peer reviewed